Professional Bladder Cancers and the Profession of Painter
NEVPP
1 other identifier
observational
150
1 country
6
Brief Summary
This is a retrospective study on bladder cancer in French painters' population. The French agency ANSES collected data from all occupational and environmental diseases center in a specific database called RNV3P. We selected cases of bladder cancer in painters in four centers from 01/01/2010 to 31/12/2019. Those cases were analyzed in terms of occupational exposure, histology and sociodemographics data. Comparison between different histologic types of cancer, workplaces and occupational diseases process will be done.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Shorter than P25 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 28, 2022
CompletedFirst Submitted
Initial submission to the registry
April 4, 2022
CompletedFirst Posted
Study publicly available on registry
July 10, 2023
CompletedJuly 10, 2023
July 1, 2023
11 months
April 4, 2022
July 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
histological type of bladder cancer
international classification of bladder cancer TNM and histology
Inclusion ( Day 0)
Secondary Outcomes (1)
Occupational exposures
Inclusion (Day 0)
Eligibility Criteria
workers with occupational work tasks of painting with medical consultation for bladder cancer in a French occupational diseases center
You may qualify if:
- painters
- age\> 18 years
- data from one of the French occupational diseases centers
- approval letter
You may not qualify if:
- non-approval letter
- age \< 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
CHRU de Brest
Brest, 29609, France
CHU de Caen
Caen, France
Ch Cherbourg
Cherbourg, France
CH le Havre
Le Havre, France
CHU de Lille
Lille, France
CHU de Rouen
Rouen, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2022
First Posted
July 10, 2023
Study Start
March 15, 2021
Primary Completion
January 28, 2022
Study Completion
January 28, 2022
Last Updated
July 10, 2023
Record last verified: 2023-07